Company Overview of Apexigen Inc.
Apexigen Inc. operates as a biopharmaceutical product development company. It focuses on development of product candidates for life-threatening and difficult to treat diseases. The company’s products include humanized antibodies for cancer, inflammatory diseases, and ophthalmic diseases. It discovers and develops rabbit-derived humanized monoclonal antibodies. The company was founded in 2010 and is based in Burlingame, California.
863 Mitten Road
Burlingame, CA 94010-1303
Founded in 2010
Key Executives for Apexigen Inc.
Apexigen Inc. Key Developments
Similar Private Companies By Industry
|Lineagen, Inc.||United States|
|Olympus Biotech Corporation||United States|
|Dios Therapeutics, Inc.||United States|
|BSF AG Research Inc.||United States|
|Biological & Popular Culture, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Apexigen Inc., please visit www.apexigen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.